Woodline Partners LP Purchases 76,527 Shares of Becton, Dickinson and Company $BDX

Key Points

• Woodline Partners LP increased its stake in Becton, Dickinson and Company (BDX) by 55.0%, owning 215,736 shares valued at approximately $49.4 million.
• Becton, Dickinson and Company reported earnings of $3.68 per share for the last quarter, exceeding analysts' expectations, and has set its FY 2025 guidance at 14.300-14.450 EPS.
• The company announced a quarterly dividend of $1.04, contributing to an annualized dividend yield of 2.2%, with a payout ratio of 74.82%.

Woodline Partners LP grew its position in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 55.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 215,736 shares of the medical instruments supplier's stock after buying an additional 76,527 shares during the quarter. Woodline Partners LP owned approximately 0.08% of Becton, Dickinson and Company worth $49,416,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in the company. Brighton Jones LLC increased its holdings in shares of Becton, Dickinson and Company by 98.2% during the 4th quarter. Brighton Jones LLC now owns 1,770 shares of the medical instruments supplier's stock valued at $401,000 after acquiring an additional 877 shares during the last quarter. Hara Capital LLC raised its position in Becton, Dickinson and Company by 26.4% in the fourth quarter. Hara Capital LLC now owns 335 shares of the medical instruments supplier's stock worth $76,000 after purchasing an additional 70 shares in the last quarter. Jefferies Financial Group Inc. raised its holdings in shares of Becton, Dickinson and Company by 76.1% in the 4th quarter. Jefferies Financial Group Inc. now owns 21,884 shares of the medical instruments supplier's stock worth $4,965,000 after buying an additional 9,457 shares in the last quarter. Investor s Fiduciary Advisor Network LLC acquired a new position in Becton, Dickinson and Company in the fourth quarter valued at about $473,000. Finally, Investment Management Corp of Ontario boosted its position in Becton, Dickinson and Company by 34.4% in the fourth quarter. Investment Management Corp of Ontario now owns 12,912 shares of the medical instruments supplier's stock valued at $2,929,000 after buying an additional 3,303 shares in the last quarter. 86.97% of the stock is currently owned by institutional investors and hedge funds.

Becton, Dickinson and Company Stock Down 1.8%

BDX stock traded down $3.34 during mid-day trading on Friday, reaching $187.23. The company had a trading volume of 1,118,088 shares, compared to its average volume of 2,576,966. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.10 and a quick ratio of 0.62. The stock has a 50 day simple moving average of $186.24 and a two-hundred day simple moving average of $192.03. The company has a market capitalization of $53.66 billion, a price-to-earnings ratio of 33.67, a PEG ratio of 1.41 and a beta of 0.27. Becton, Dickinson and Company has a 52 week low of $163.33 and a 52 week high of $251.99.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $3.68 earnings per share for the quarter, beating analysts' consensus estimates of $3.40 by $0.28. The firm had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.50 billion. Becton, Dickinson and Company had a return on equity of 16.23% and a net margin of 7.51%.The business's revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company earned $3.50 earnings per share. Becton, Dickinson and Company has set its FY 2025 guidance at 14.300-14.450 EPS. As a group, equities analysts predict that Becton, Dickinson and Company will post 14.43 earnings per share for the current fiscal year.

Becton, Dickinson and Company Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Monday, September 8th will be paid a $1.04 dividend. The ex-dividend date is Monday, September 8th. This represents a $4.16 annualized dividend and a yield of 2.2%. Becton, Dickinson and Company's dividend payout ratio is currently 74.82%.

Wall Street Analyst Weigh In

BDX has been the subject of several research reports. Wells Fargo & Company raised their price objective on shares of Becton, Dickinson and Company from $172.00 to $184.00 and gave the company an "equal weight" rating in a research report on Friday, August 8th. Wall Street Zen raised shares of Becton, Dickinson and Company from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Barclays reduced their target price on Becton, Dickinson and Company from $261.00 to $241.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. Morgan Stanley increased their target price on Becton, Dickinson and Company from $196.00 to $197.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Finally, Piper Sandler reissued a "neutral" rating and set a $200.00 target price (up from $185.00) on shares of Becton, Dickinson and Company in a research note on Friday, August 8th. Four research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $211.44.

Insider Activity at Becton, Dickinson and Company

In other Becton, Dickinson and Company news, Director Claire Fraser sold 917 shares of the company's stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $187.50, for a total value of $171,937.50. Following the sale, the director owned 22,226 shares in the company, valued at $4,167,375. This represents a 3.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael David Garrison sold 1,185 shares of the company's stock in a transaction that occurred on Friday, July 18th. The shares were sold at an average price of $180.29, for a total value of $213,643.65. Following the completion of the sale, the executive vice president owned 4,887 shares in the company, valued at $881,077.23. This represents a 19.52% decrease in their position. The disclosure for this sale can be found here. Insiders sold 2,965 shares of company stock worth $551,536 in the last 90 days. Corporate insiders own 0.36% of the company's stock.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.